公募周调研次数大增149% 科技与医药仍是“最爱”

Group 1 - The core viewpoint of the article highlights the increasing research efforts by public funds, with a significant rise in the number of companies being investigated and the frequency of these investigations [1] - During the week of August 18 to August 24, 2025, 151 public funds participated in the research of 155 A-share listed companies, resulting in a total of 1,817 investigations, which represents a 149.25% increase compared to the previous week [1] - The electronic and pharmaceutical industries were among the most frequently researched sectors, with specific companies like Unisoc and Kaili Medical receiving notable attention [1] Group 2 - Jin Ying Fund suggests focusing on technology, innovative pharmaceuticals, non-bank financials, and the non-ferrous metals industry for future investments based on long-term profit improvement logic [1] - In the technology sector, AI chains are currently at a peak of trading sentiment, and the development of both domestic and overseas AI markets is seen as complementary, with a recommendation to pay attention to stocks with relatively favorable price-earnings ratios in AI applications and advanced semiconductor processes [1] - The expectation of a Federal Reserve interest rate cut and the establishment of a dual easing monetary and fiscal environment overseas in 2026 is anticipated to benefit export-oriented sectors such as innovative pharmaceuticals, non-ferrous metals, and home appliances, presenting new investment opportunities [1]